During kidney development, the ureteric bud, a tubular outgrowth of the Wolffian duct, develops into the epithelium of the urinary collecting system through a complex process of branching morphogenesis. These events are controlled largely by signals to the ureteric bud cells from an adjacent population of mesenchymal cells, called the metanephric mesenchyme, and several of the responsible growth factors and their receptors have been identified [1] [2] [3] . In a reciprocal inductive process, factors secreted by the ureteric bud induce progenitor cells in the metanephric mesenchyme to condense, epithelialize and differentiate into nephrons, the functional units of the kidney 2-4 . Defects in ureteric bud branching morphogenesis can lead to reduced numbers of nephrons, which has been linked to the progression of renal diseases and hypertension 5 .
During kidney development, the ureteric bud, a tubular outgrowth of the Wolffian duct, develops into the epithelium of the urinary collecting system through a complex process of branching morphogenesis. These events are controlled largely by signals to the ureteric bud cells from an adjacent population of mesenchymal cells, called the metanephric mesenchyme, and several of the responsible growth factors and their receptors have been identified [1] [2] [3] . In a reciprocal inductive process, factors secreted by the ureteric bud induce progenitor cells in the metanephric mesenchyme to condense, epithelialize and differentiate into nephrons, the functional units of the kidney [2] [3] [4] . Defects in ureteric bud branching morphogenesis can lead to reduced numbers of nephrons, which has been linked to the progression of renal diseases and hypertension 5 .
One secreted protein that has a crucial role in ureteric bud growth and branching is glial cell line-derived neurotrophic factor (GDNF), which is produced by the metanephric mesenchyme cells. GDNF signals through the receptor tyrosine kinase Ret and the coreceptor GDNF family receptor-α1 (Gfrα1; ref. 6) , which are coexpressed in the Wolffian duct and later at the tips of the ureteric bud. The ablation of any of these genes in mice results in absence of the kidney (agenesis), owing to failure of ureteric bud outgrowth, or severe malformation (hypodysplasia), owing to very limited ureteric bud branching 7 . In humans, RET mutations are associated with renal agenesis, Hirschsprung disease and cancer 6, 8 . GDNF signaling results in ureteric bud cell proliferation, cell survival and branching of the epithelium, but the precise mechanisms by which GDNF exerts its effects on ureteric bud cells remain to be elucidated 7 .
Some of the genes regulated by GDNF are likely to promote cell proliferation, movement, adhesion or shape changes and thus contribute to morphogenesis of the epithelium. Others may encode inductive proteins secreted by the ureteric bud or promote differentiation of collecting duct cells. Only a few genes regulated by GDNF have been identified, and none of them can account for the profound effects of GDNF on ureteric bud morphogenesis. For this reason, we conducted a genome-wide analysis of mRNA expression in isolated ureteric buds cultured with or without GDNF. Among the genes identified were two members of the Pea3 family of ETS transcription factors 9 , Etv4 (Pea3) and Etv5 (Erm). Etv4 and Etv5 are important in neuronal, spermatogonial and limb development [10] [11] [12] , but a role in renal development had not been investigated. Here we show that overlapping expression of Etv4 and Etv5 in ureteric bud tip cells is positively regulated by GDNF-Ret signaling and that these transcription factors are jointly required for kidney development. Thus, mice lacking both Etv4 alleles and one Etv5 allele have a high frequency of renal agenesis or hypodysplasia owing to branching defects, whereas mice completely deficient in Etv4 and Etv5 show a complete absence of kidney development. We also identified several genes whose expression in the ureteric bud tips depends on Etv4 and Etv5 and that together may contribute to the defects seen in kidneys mutant for Etv4 and Etv5, or for Gdnf, Ret or Gfra1. These studies 
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begin to elucidate a gene regulatory network activated by GDNF that controls ureteric bud branching morphogenesis.
RESULTS

A screen for GDNF-regulated genes in the ureteric bud
To identify genes whose expression is altered by GDNF-Ret signaling, we took advantage of the ability of isolated ureteric buds to grow and branch in the absence of mesenchyme when cultured in GDNF-supplemented Matrigel 13 . We removed the mesenchyme from embryonic day 11.5 (E11.5) metanephroi and cultured the ureteric buds overnight with or without GDNF (Fig. 1a) . Without GDNF, the ureteric buds did not grow or branch appreciably 13 but, after 16 h, remained viable and capable of resuming growth when GDNF was added.
We surveyed Affymetrix mouse gene chips U74Av2 and 430A using RNA from three pools of ureteric buds grown with GDNF and two pools grown without. Of the ~12,000 transcripts represented on the U74Av2 array, 89 were upregulated by two-fold or more with GDNF, 14 by three-fold or more and 4 by four-fold or more, whereas only 3 were downregulated by twofold or more. Of the 22,626 transcripts represented on the 430A array, 78 were upregulated by two-fold or more, 6 by three-fold or more and 3 by four-fold or more, and 4 were downregulated by two-fold or more. Table 1 lists the genes most highly upregulated by GDNF (more extensive lists are provided in Supplementary Tables 1 and 2) . The validity of the screen was supported, first, by the fact that eight of these genes had been independently identified as GDNF-Ret targets in the ureteric bud (Wnt11, Ret and Spry1) or other cell types (Etv4, Etv5, Cxcr4, Ccnd1 and Dusp6) 10, [14] [15] [16] [17] [18] [19] [20] . A second criterion was that genes upregulated by GDNF should be more highly expressed in the ureteric bud tip, the subdomain of epithelium where Ret and Gfra1 are expressed, than in the trunk. We examined 12 of the listed genes by in situ hybridization (ISH), and all showed tip-specific expression in the ureteric bud (Figs. 1b-h and 2 and data not shown).
A third criterion for positive regulation by GDNF was reduced expression in a hypomorphic Ret mutant in which GDNF-Ret signaling is reduced 15 . We examined the expression of nine GDNF-upregulated genes in Ret-hypomorphic kidneys, and all were markedly reduced in the mutant ureteric bud tips (Figs. 1b-h and 3) .
The genes we found to be upregulated by GDNF encode secreted factors (Wnt11 and Crlf1), receptors (Cxcr4 and Ret), regulators of signal transduction (Spry1, Dusp6 and Spred2), transcription factors (Etv5, Myb, E2f8 and Etv4) and enzymes (Arg2 and Car2). Several are associated with DNA replication, mitosis and cell cycle regulation (including Myb, Ect2, Ccnd1, Ccnb1 and Ncaph), consistent with a role of GDNF in proliferation of ureteric bud tip cells 14, 21 . We hypothesized that these genes together mediate the effects of GDNF on branching morphogenesis and that mutations in some of them may reveal roles in kidney development. Only Ret, Wnt11 and Spry1 are known to be required for normal ureteric bud branching morphogenesis 16, 22, 23 , whereas most of the others have been knocked out but caused no reported renal defects or caused early embryonic lethality [24] [25] [26] . More complex genetic approaches, such as double or conditional knockouts, may therefore be required to reveal potential functions during kidney development.
Etv4 and Etv5 are primarily regulated by GDNF Our identification of two closely related genes, Etv4 and Etv5, in the GDNF screen, together with their roles in other developing systems, suggested that they encode key transcription factors that mediate the effects of extracellular cues during kidney development. Both genes are expressed in several organs undergoing branching morphogenesis, including the lung, mammary and salivary glands and kidney 27 . We surveyed their expression during kidney development and found that both Etv4 and Etv5 are expressed in a pattern similar to that of Ret: in the Wolffian duct at E9.5 and E10.5 ( Fig. 2a-d) , in the T-shaped ureteric bud at E11.5 ( Fig. 2e-h ) and in the ureteric bud tips throughout subsequent development (Fig. 2i-k) . Unlike Ret, they are also expressed in the metanephric mesenchyme and nascent nephrons, but at lower levels than in the ureteric bud ( Fig. 2g-j) . The third Pea3 family member, Etv1, was not detectably expressed in E14.5 and E18.5 kidneys (data not shown).
To further test whether Etv4 and Etv5 are regulated by GDNF, we conducted gain-and loss-of-function studies. Culture of kidneys heterozygous for the Etv4 tm1Arbr (referred to here as Etv4 lacZ ) or Etv5 lacZ (see Online Methods) alleles with GDNF-soaked beads caused elevated lacZ expression in the ureteric bud tips close to the beads (Fig. 3a,b) , confirming upregulation by GDNF. Conversely, in Ret-hypomorphic kidneys (Fig. 3c-f) or normal kidneys cultured with GDNF-blocking antibody ( Supplementary Fig. 1a-d) , Etv4 and Etv5 expression was greatly reduced.
Etv4 and Etv5 are regulated by fibroblast growth factors (FGFs) in several developing organs 12, 28, 29 . The two FGFs implicated in ureteric bud branching in vivo are FGF7 and FGF10, which are expressed in the metanephric mesenchyme and stroma 30 and signal to the ureteric bud, mainly through FGF receptor 2 (FGFR2). In Fgf10 −/− kidneys or kidneys in which Fgfr2 is deleted in the ureteric bud-both of which are hypoplastic with reduced ureteric bud branching 31,32 -Etv4 and Etv5 expression remained normal ( Supplementary Fig. 2a-h ). Thus, in the developing ureteric bud, normal expression of Etv4 and Etv5 depends strongly on GDNF-Ret signaling, but apparently not on FGF7 or FGF10 signaling through FGFR2, and the defects in kidneys mutant for Fgf7, Fgf10 and Fgfr2 (in the ureteric bud) are evidently not caused by reduced Etv4 and Etv5 expression. However, Etv4 and Etv5 expression in the ureteric bud can be upregulated by exogenous FGF10 (but not FGF7), as shown by culturing kidneys with FGF-soaked beads (Supplementary Figs. 1e,f and 2i-n).
Ret signaling activates several intracellular signal transduction pathways, including Erk MAP kinase, phosphatidylinositol-3-kinase (PI3K) and phospholipase C (PLC)-γ (ref. 6 ). To investigate the mechanism that leads to expression of Etv4 and Etv5, we used mutant mice and pharmacological inhibitors. Ret Tyr1015 is required for PLC-γ activation, and the Ret mutation resulting in Y1015F (Ret Y1015F ) results in decreased ureteric bud branching 33 . However, Etv4 and Etv5 were expressed normally in Ret Y1015F/-kidneys ( Supplementary  Fig. 3a-d) , indicating that PLC-γ signaling is dispensable for their expression. Mutation of Ret Tyr1062 reduces (but does not eliminate) both Erk MAP kinase and PI3K signaling and causes reduced ureteric bud branching in vivo 34 . Ret Y1062F mutant kidneys expressed Etv4 and Etv5 at normal levels ( Supplementary Fig. 3e-h ). As there is not a Ret mutation that specifically eliminates Erk or PI3K signaling, we used specific chemical inhibitors of these pathways in wild-type kidney cultures. Each inhibitor substantially reduced ureteric bud branching, as previously reported 35, 36 , but the PI3K inhibitor eliminated Etv4 and Etv5 expression in the ureteric bud, whereas the Erk MAP kinase inhibitor had little or no effect on expression ( Supplementary  Fig. 3i-x) . Thus, the PI3K pathway seems to be crucial for expression of Etv4 and Etv5 in the ureteric bud tips.
Etv4 and Etv5 are both required for normal kidney development
To determine the importance of Etv4 and Etv5 in kidney development, we examined fetal and newborn mice with single or compound mutations. We initially used the Etv4 lacZ (ref. 10) and Etv5 lacZ knockin and knockout alleles, which delete exons encoding the DNA binding domains ( Fig. 4a-h ). Whereas Etv4 +/− and Etv5 +/− heterozygotes were normal, Etv4 −/− homozygotes and Etv4 +/− ; Etv5 +/− compound . 4d , right side, and Supplementary Table 3b) , although the mice were grossly normal. The hypoplastic kidneys were small, cystic, lacked a nephrogenic zone and had greatly reduced tubular elements and glomeruli (Fig. 4f) , but the few glomeruli were apparently normal (Fig. 4h) . Etv4 and Etv5 are therefore functionally redundant and collectively support kidney development. We next examined a second Etv5 allele 11 , Etv5 tm1Kmm (abbreviated Etv5 M ), in which exons 2-5, including the initiation codon, were deleted ( Fig. 4i-m) . Etv5 M is apparently weaker than Etv5 lacZ , as Etv5 M/M homozygotes were viable and Etv4 −/− ; Etv5 +/M mutants had less frequent renal defects (Fig. 4j) Fig. 4k and Supplementary Table 3c) , which was disorganized and showed no signs of ureteric bud branching or nephrogenesis (Fig. 4m) . Despite the differences in severity of the two Etv5 alleles, their qualitatively similar effects (combined with Etv4 mutation) leave no doubt that these two ETS transcription factors have crucial and overlapping roles in kidney development. Thus, our studies identify, for the first time, two genes that are targets of the GDNF-Ret pathway and when mutated recapitulate the phenotype of Gdnf, Ret or Gfra1 mutants.
Renal phenotype results from ureteric bud branching defect
To examine the cause of the renal agenesis and hypoplasia in Etv4 −/− ; Etv5 +/− mutants, we examined ureteric bud branching by introducing a Tg(Hoxb7-myrVenus) transgene expressing a fluorescent protein in the Wolffian duct and ureteric bud 37 . At E11.5-E12.5, when the ureteric bud would normally have emerged and started to branch, 16% of ureteric buds were absent, 40% showed no branching and ; Etv5 
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19% showed retarded branching (Fig. 5a-d and Supplementary Table 4) . At later stages, kidneys were often absent, and when present contained a reduced number and irregular pattern of ureteric bud tips ( Fig. 5e-j) . Thus, defects in ureteric bud formation and branching seem to underlie the severe renal defects, consistent with a role for Etv4 and Etv5 downstream of GDNF-Ret signaling. As Etv4 and Etv5 are expressed in the metanephric mesenchyme and ureteric bud, a deficiency in one or both lineages might contribute to branching defects. To test their requirement in the ureteric bud lineage, we cultured mutant ureteric buds free of metanephric mesenchyme and under conditions in which wild-type buds grow and branch extensively 13 . None of the four Etv4 −/− ; Etv5 +/− ureteric buds branched significantly, whereas the majority (11 of 17) with only one or two mutant alleles branched extensively ( Fig. 5k-m ; P < 0.05 by t-test). This confirms that Etv4 and Etv5 are together important in the ureteric bud lineage for growth and branching.
Identification of genes regulated by Etv4 and Etv5
Because Etv4 and Etv5 are transcription factors, we hypothesized that the renal defects in compound mutants result from an inability to regulate their target genes. We therefore examined the expression of a variety of candidate genes by ISH or immunofluorescence, using kidneys from Etv4 −/− ; Etv5 +/− embryos (rather than Etv4 −/− ; Etv5 M/M double homozygotes, which had no renal tissue to analyze).
The expression of Gdnf and several other genes with important roles in the metanephric mesenchyme (Wt1, Six1, Six2, Eya1 and Pax2) was not significantly altered in the metanephric mesenchyme of hypoplastic Etv4 −/− ; Etv5 +/− kidneys, nor were markers of nascent nephron epithelia (Lhx1, Jag1 and Pax2), podocytes (Wt1 and Lhx1) or stroma (Foxd1; Supplementary Fig. 4 ). This is consistent with the morphologically normal glomerular differentiation in these mutant kidneys (Fig. 4h) .
We next examined several of the genes positively regulated by GDNF-Ret signaling in the ureteric bud tips ( Fig. 1 and Table 1 ) in hypoplastic Etv4 −/− ; Etv5 +/− kidneys. At E15.5, Crlf1, Dusp6, Etv5 and Spry1 were expressed at close to normal levels ( Fig. 6 and data not shown). Ret remained highly expressed in many mutant ureteric bud tips, although it was low in a subset of the tips, whereas Wnt11 was uniformly reduced. However, at E13.5, expression of Ret (data not shown) and Wnt11 (Fig. 6i) was normal, suggesting that their reduced expression at E15.5 is a secondary effect of the progressively abnormal renal development in Etv4 −/− ; Etv5 +/− mutants. In contrast, expression of the chemokine receptor Cxcr4 and the transcription factor Myb was strongly reduced in the mutant kidneys at both E13.5 and E15.5 (Fig. 6f,g,j,k) , suggesting they are more likely to be primary targets of Etv4 and Etv5 activity.
We also examined Met and the matrix metalloproteinase Mmp14, which were not identified in our screen as GDNF targets (perhaps for technical or biological reasons, such as effects of Matrigel or culture medium on gene regulation, or low expression at E11.5) 
A r t i c l e s
but are regulated by Etv4 in other cell types and have been implicated in kidney development [38] [39] [40] [41] . Met, the tyrosine kinase receptor for hepatocyte growth factor (HGF), is regulated by Etv4 in motor neurons 42 and is expressed in ureteric bud tips. Met mRNA was markedly reduced in Etv4 −/− ; Etv5 +/− kidneys at both E13.5 and E15.5 ( Fig. 6h,l) . Consistent with its regulation by Etv4, Met expression was absent in the ureteric buds of Ret-hypomorphic kidneys (data not shown). Mmp14 is likely to be a direct target of Etv4 in tumor cells 43 and is implicated in branching morphogenesis in kidney and other organs 39, [44] [45] [46] . In wild-type kidneys, Mmp14 was detected in the ureteric bud, metanephric mesenchyme and peripheral stroma, whereas in Etv4 −/− ; Etv5 +/− kidneys, it was strongly reduced in both the ureteric bud and metanephric mesenchyme (Fig. 7a-h) .
Similarly, in Ret-hypomorphic kidneys, Mmp14 was greatly diminished in both ureteric bud and metanephric mesenchyme (Fig. 7i-l) .
Because Ret is only expressed in the ureteric bud, the reduced expression of Mmp14 in metanephric mesenchyme is likely to be an indirect effect of the Ret mutation. Consistent with this interpretation, Mmp14 mRNA is normally expressed in the ureteric bud and the stroma, but not the metanephric mesenchyme (Fig. 7m) , and it is downregulated in the ureteric bud of Ret-hypomorphic kidneys (Fig. 7n) ; the Mmp14 we observed in the metanephric mesenchyme was therefore probably shed from the ureteric bud, a known property of Mmp14 (ref. 47) . We concluded that Mmp14 is normally expressed in the ureteric bud, where it is positively regulated by Ret signaling through Etv4 and Etv5, and in the stroma, where it is independent of these mechanisms.
DISCUSSION
To identify genes that mediate the important effects of Ret signaling on branching morphogenesis, we conducted a screen for genes whose expression is altered by GDNF in ureteric bud cultures. In addition to several previously described GDNF targets in the ureteric bud (Ret, Wnt11 and Spry1) or other cell types (Etv4 and Etv5), we identified several new downstream genes, including Cxcr4, Crlf1, Myb and Dusp6. We then focused on the roles of the transcription factors Etv4 and Etv5, finding that they show largely overlapping expression throughout kidney development and are positively regulated by GDNF-Ret signaling in ureteric bud tips. Genetic crosses revealed that mice lacking three of the four Etv4 and Etv5 alleles have moderate to severe defects in renal development owing to reduced ureteric bud branching, whereas those lacking all four alleles do not develop kidneys. We next identified four genes whose expression is greatly reduced in the hypoplastic kidneys of Etv4 −/− ; Etv5 +/− compound mutants and thus represent direct or indirect targets of these transcription factors. Cxcr4, Met, Mmp14 and Myb may participate in different aspects of epithelial morphogenesis, and collectively, their reduced expression is likely to contribute to the renal defects in mice with Etv4 and Etv5 mutations, as well as those with Ret, Gdnf or Gfra1 mutations (Supplementary Fig. 5 ). Etv4 and Etv5 are transcriptionally regulated by FGFs in several organs 12, 28, 29 , and FGFRs activate several signaling pathways common to Ret 48 . It was therefore surprising that renal expression of Etv4 and Etv5 was unaffected by Fgf10 or Fgfr2 mutations. It is most likely that the strong GDNF-Ret signaling in the ureteric bud overwhelmed the effects of FGF signaling, so a reduction in the latter had no noticeable effect on Etv4 and Etv5 expression. However, Etv4 and Etv5 expression was increased in kidneys cultured with exogenous FGF10, indicating that they can be regulated by signaling pathways common to FGFRs and Ret. Experiments with signaling inhibitors suggested that the PI3K pathway (activated by both Ret and FGFRs) is one of these.
The inability of FGF7 to upregulate Etv4 and Etv5 may underlie the distinct effects of FGF7 and FGF10 on branching of isolated ureteric buds; only the latter induces formation of elongated tubules with distinct ampullae 49 .
Etv4 and Etv5 are most strongly expressed in the Wolffian ductureteric bud lineage, and in the Etv4 −/− ; Etv5 +/− mutants, the ureteric bud either did not emerge from the Wolffian duct or was defective in later branching. This is consistent with a cell-autonomous role of Etv4 and Etv5 within ureteric bud cells, downstream of GDNFRet signaling. It is possible that Etv4 and Etv5 also function in the metanephric mesenchyme lineage, indirectly, to promote ureteric bud growth and branching. However, the normal expression levels of several important mesenchymally expressed genes (including Gdnf) in Etv4 −/− ; Etv5 +/− mutant kidneys, as well as the inability of isolated ureteric buds to branch in culture, suggest that the branching defects are intrinsic to the mutant ureteric bud epithelium. Etv4 −/− ; Etv5 +/− kidneys contained apparently normal glomeruli (in reduced numbers), whereas the more severely affected Etv4 −/− ; Etv5 M/M kidneys lacked any sign of nephrogenesis, which could result from either a role of Etv4 and Etv5 in the nephron lineage or an inability of the mutant ureteric bud to induce nephrogenesis.
To begin to identify both direct and indirect targets of Etv4 and Etv5, we examined the expression of a variety of candidate genes in hypoplastic Etv4 −/− ; Etv5 +/− kidneys. Many genes, several of which are regulated by GDNF in the ureteric bud tips, showed essentially normal expression. Thus, either a single Etv5 allele is sufficient for their normal expression, or they are regulated by mechanisms independent of Etv4 and Etv5 (Supplementary Fig. 5 ). In either case, they are not among the genes responsible for the phenotypic defects in Etv4 −/− ; Etv5 +/− kidneys. However, we identified four genes whose expression in the ureteric bud tips was strongly reduced in the mutants and may contribute to the renal phenotypes.
Cxcr4 and its ligand Cxcl12 have important roles in cell migration in many situations 50 . During kidney development, Cxcr4 is expressed similarly to Etv4 and Etv5, in the Wolffian duct and ureteric bud tips, metanephric mesenchyme and nascent nephrons (Fig. 6 and data not shown). In our microarray screen, Cxcr4 was highly upregulated by GDNF, and its expression was barely detectable in either Ret-hypomorphic or Etv4 −/− ; Etv5 +/− kidneys. In a breast cancer cell line, CXCR4 is regulated by the ETS factor Ets1 (ref. 51) , which binds the same GGAA/T core motif as do Etv4 and Etv5, suggesting that Cxcr4 is a direct target of Etv4 and Etv5 in ureteric bud cells. Cxcr4 might contribute to Ret-dependent epithelial cell movements during renal branching morphogenesis 52, 53 , although the Cxcr4 knockout alone has no major effects on ureteric bud branching 54 .
Myb encodes a transcription factor with documented roles in hematopoiesis, colon crypt maintenance, adult brain neurogenesis and cancer 55 . Notably, in these organs it seems to promote the proliferation of a stem or progenitor cell population while dampening cell differentiation 55 . Given its specific expression in ureteric bud tips, a proliferative cell population 21 that both self-renews and gives rise to differentiated derivatives in the ureteric bud trunks 52, 56 (P. Riccio and F.C., unpublished data), Myb might function downstream of Ret, Etv4 and Etv5 to maintain the proliferation of tip cells. Transcription of Myb, like that of Cxcr4, can be regulated by Ets1 (refs. 57, 58) , so it might be a direct target of Etv4 and Etv5 in the kidney. Kidney defects were not reported in Myb −/− mice, which die at E15.5, or in hypomorphic Myb mutants that survive postnatally. However, this might result from redundancy with the closely related gene Mybl2 (ref. 52) , which is also expressed in the ureteric bud (B.C.L. and F.C., unpublished data).
We examined Met because it is upregulated by Gdnf and Etv4 in motor neurons 42 and is a direct Ets1 target in cell lines 59 . Met expression in ureteric bud tips was greatly reduced in both Etv4 −/− ; Etv5 +/− and Ret-hypomorphic kidneys. HGF, the Met ligand, is expressed in the metanephric mesenchyme and stroma 60 and promotes branching in MDCK canine kidney cells and renal organ cultures 60, 61 . Furthermore, a ureteric bud-specific knockout revealed that Met contributes to ureteric bud branching in cooperation with epidermal growth factor receptor 38 . In motor neurons, Gdnf first induces Etv4 expression, which activates Met expression, allowing HGF to further induce Etv4 (ref. 42) . A similar positive feedback mechanism might occur in the kidney (Supplementary Fig. 5) .
Matrix metalloproteinases promote branching morphogenesis by degrading components of the extracellular matrix, thus remodeling the matrix and releasing bound growth factors 44, 45 . Several Mmp genes have been identified as potentially direct Etv4 targets 62 ; among these, Mmp14 is expressed in the ureteric bud 40, 46 and can be transactivated by Etv4 (ref. 43) . Mmp14 has been implicated in branching in kidney 39 and ureteric bud cell cultures 40 , and Mmp14 −/− mice have hypoplastic kidneys, suggesting a branching defect 41 (R. Zent and K. Riggins, personal communication). We found that Mmp14 expression was considerably reduced in both Etv4 −/− ; Etv5 +/− and Ret-hypomorphic kidneys, indicating that another function of Etv4 and Etv5 is to upregulate Mmp14 in the ureteric bud.
In conclusion, our studies show that Etv4 and Etv5 are key components of a gene network downstream of Ret that promotes and controls renal branching morphogenesis. As RET mutations in humans result in renal abnormalities 8 , these findings are likely to be important for our understanding of the causes of renal birth defects in humans. 
METHODS
Methods
ONLINE METHODS
Ureteric bud cultures and Affymetrix array analysis. Ureteric buds were dissected from Swiss Webster mouse embryos at E11.5 and cultured in Matrigel (BD Biosciences) with 2× conditioned medium from BSN (immortalized cell line derived from murine E11.5 metanephric mesenchyme) cells and 10% FCS, with or without 100 ng/ml GDNF 49 . They were then removed from the Matrigel, homogenized in TRIzol and 25 ng/µl glycogen, and stored at −80 °C. RNA was isolated from batches of 30-40 pooled ureteric buds, quantified and checked for integrity using an Agilent 2100 Bioanalyzer. Approximately 8 µg of total RNA (from 200-250 ureteric buds) was used to generate an amount of unamplified probe sufficient for each Affymetrix array. The RNAs were subjected to reverse transcription, second-strand synthesis and probe generation according to the Expression Analysis Technical Manual (Affymetrix). The same five probe preparations (from three pools of ureteric buds cultured with GDNF and two pools without GDNF) were used for hybridization to U74Av2 and 430A arrays. Hybridization, scanning and low-level analysis (generation of raw expression data) were done by a core facility of the Herbert Irving Comprehensive Cancer Center. Sample comparisons and statistical analysis were conducted with dChip 1.3 (ref. 63) , using the Comparison Analysis feature to identify genes differentially expressed between the two groups. The following filtering criteria were used: the lower limit for fold change between means of the samples with and without GDNF must exceed 1.2, with 90% confidence limit, and the absolute difference between the two group means must exceed 100. 33 have been described. To generate the Etv5 lacZ targeting vector, a partial genomic clone of Etv5 was isolated from a 129/Sv mouse genomic phage library. A 4-kb PstI-XhoI DNA fragment containing exon 10 and part of exon 11 was cloned 5′ to IRES-lacZ and PGK-neo in pBluescript. A 5.2-kb BamHI-NotI Etv5 genomic fragment containing exon 13 was used for the 3′ homology arm (NotI is from phage sequence). The vector was electroporated into W9.5 embryonic stem cells and targeted clones identified by Southern blotting (data not shown). The targeted allele thus lacks most of exon 11 and all of exon 12, resulting in loss of the DNA binding domain. Structure of the Etv4 lacZ and Etv5 lacZ alleles and genotyping is described in Supplementary  Figure 6 and Supplementary Table 5 . Etv5 tm1Kmm mice were genotyped by PCR as described 11 . The experimental design used in this study was approved by the Columbia University Medical Center animal care and use committee.
Immunofluorescence. Cryosections were washed in PBS, permeabilized in PBS with 0.1% Triton X-100 and blocked in blocking buffer (PBS, 0.05% Triton X-100 and 1% normal donkey serum). Antibodies to Etv4 (1:50; ref. 65) or Mmp14 (1:200; Sigma) were diluted in blocking buffer. Cy2-or Cy3-conjugated secondary antibodies (Jackson ImmunoResearch) were diluted in blocking buffer. Images were taken with Zeiss LSM510 Meta or Axio Observer microscopes.
In situ hybridization. Embryos or dissected kidneys were fixed in 4% paraformaldehyde overnight at 4 °C, and cryosections were obtained by standard procedures. For vibratome sections, fixed tissues were washed in PBS and embedded in 0.3% gelatin, 20% BSA and 13% sucrose, which was polymerized with 1% glutaraldehyde. Sections 75 µm thick were cut and fixed for 20 min in 4% paraformaldehyde before whole-mount ISH, which was carried out using digoxigenin-labeled probes as described 66 .
Organ cultures and induction with growth factor-soaked beads. Kidneys or lungs were isolated at the indicated stages and cultured on Transwell filters (Fisher) at the air-medium interface in DMEM with 10% FCS, 1% glutamine and 1% penicillin-streptomycin at 37 °C in 5% CO 2 . For GDNF beads, Affi-Gel blue beads (100-200 mesh; Bio-Rad) were washed with PBS and 0.1% BSA before being incubated with 50 ng/µl recombinant GDNF. FGF7 or FGF10 beads were prepared as described 67 . Blocking antibody to GDNF (R&D Systems) was used at 5 µg/ml.
